Previous Page  20 / 22 Next Page
Information
Show Menu
Previous Page 20 / 22 Next Page
Page Background

Page 53

S e p t e m b e r 0 6 - 0 7 , 2 0 1 8 | B a n g k o k , T h a i l a n d

Note:

allied

academies

Joint Event on

Global Women Health 2018 & Orthopedics Congress 2018

Archives of General Internal Medicine

|

ISSN: 2591-7951

|

Volume 2

BREAST CANCER, GYNECOLOGY AND WOMEN HEALTH

ORTHOPEDICS AND RHEUMATOLOGY

&

World Congress on

Annual Conference on

Arch Gen Intern Med 2018, Volume 2 | DOI: 10.4066/2591-7951-C3-009

LIMB SPARING RECONSTRUCTIVE SURGERY AND ILIZAROV

LENGTHENING IN FIBULAR HEMIMELIA OF ACHTERMAN–KALAMCHI II

PATIENTS

Mohamed El-Sayed

1

, Johannes Correll

2

and

Kriatian Pholig

3

1

Tanta University, Egypt

2

Aschau Pediatric Orthopedic Hospital, Germany

F

ibular hemimelia is the commonest congenital deformity or absence of long bones. It encompasses a spectrum of anomalies

affecting femur, knee, tibia, ankle, and foot. It may be associated with other complex syndromes as femur fibula ulna syndrome

(FFU)a, but mostly occurs as an isolated deformity. Management of this complex deformity is controversial, and the question has

always been; is amputation a must? The aim of this study was to evaluate the long-term results of management of fibular hemimelia

(Achterman–Kalamchi, type-II) using limb reconstructive surgeries, followed by staged lengthening by the Ilizarov method. We

reviewed 157 consecutive patients (180 limb segments) with a mean follow-up period of 10.7 years (1.2–21 years). The results

were favorable, and all the patients walked independently. Although, this type of management is technically demanding and entails

a lengthy procedure with many complications anticipated, the Ilizarov lengthening after limb reconstruction is still an attractive

option for management of this type of limb deficiency.